ResearchIn-Press PreviewInfectious diseaseTherapeutics
Open Access | 10.1172/jci.insight.140267
1Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia
2Viral Immunology and Respiratory Disease Group, University of Newcastle, Newcastle, Australia
3Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia
4Department of Microbiology and Immunology, University of Melbourne, Melbourne, Australia
5Ena Therapeutics Pty Ltd, Ena Therapeutics Pty Ltd, Melbourne, Australia
Find articles by
Deliyannis, G.
in:
JCI
|
PubMed
|
Google Scholar
|
1Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia
2Viral Immunology and Respiratory Disease Group, University of Newcastle, Newcastle, Australia
3Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia
4Department of Microbiology and Immunology, University of Melbourne, Melbourne, Australia
5Ena Therapeutics Pty Ltd, Ena Therapeutics Pty Ltd, Melbourne, Australia
Find articles by Wong, C. in: JCI | PubMed | Google Scholar
1Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia
2Viral Immunology and Respiratory Disease Group, University of Newcastle, Newcastle, Australia
3Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia
4Department of Microbiology and Immunology, University of Melbourne, Melbourne, Australia
5Ena Therapeutics Pty Ltd, Ena Therapeutics Pty Ltd, Melbourne, Australia
Find articles by McQuilten, H. in: JCI | PubMed | Google Scholar
1Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia
2Viral Immunology and Respiratory Disease Group, University of Newcastle, Newcastle, Australia
3Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia
4Department of Microbiology and Immunology, University of Melbourne, Melbourne, Australia
5Ena Therapeutics Pty Ltd, Ena Therapeutics Pty Ltd, Melbourne, Australia
Find articles by Bachem, A. in: JCI | PubMed | Google Scholar
1Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia
2Viral Immunology and Respiratory Disease Group, University of Newcastle, Newcastle, Australia
3Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia
4Department of Microbiology and Immunology, University of Melbourne, Melbourne, Australia
5Ena Therapeutics Pty Ltd, Ena Therapeutics Pty Ltd, Melbourne, Australia
Find articles by Clarke, M. in: JCI | PubMed | Google Scholar
1Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia
2Viral Immunology and Respiratory Disease Group, University of Newcastle, Newcastle, Australia
3Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia
4Department of Microbiology and Immunology, University of Melbourne, Melbourne, Australia
5Ena Therapeutics Pty Ltd, Ena Therapeutics Pty Ltd, Melbourne, Australia
Find articles by Jia, X. in: JCI | PubMed | Google Scholar
1Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia
2Viral Immunology and Respiratory Disease Group, University of Newcastle, Newcastle, Australia
3Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia
4Department of Microbiology and Immunology, University of Melbourne, Melbourne, Australia
5Ena Therapeutics Pty Ltd, Ena Therapeutics Pty Ltd, Melbourne, Australia
Find articles by Horrocks, K. in: JCI | PubMed | Google Scholar
1Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia
2Viral Immunology and Respiratory Disease Group, University of Newcastle, Newcastle, Australia
3Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia
4Department of Microbiology and Immunology, University of Melbourne, Melbourne, Australia
5Ena Therapeutics Pty Ltd, Ena Therapeutics Pty Ltd, Melbourne, Australia
Find articles by
Zeng, W.
in:
JCI
|
PubMed
|
Google Scholar
|
1Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia
2Viral Immunology and Respiratory Disease Group, University of Newcastle, Newcastle, Australia
3Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia
4Department of Microbiology and Immunology, University of Melbourne, Melbourne, Australia
5Ena Therapeutics Pty Ltd, Ena Therapeutics Pty Ltd, Melbourne, Australia
Find articles by
Girkin, J.
in:
JCI
|
PubMed
|
Google Scholar
|
1Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia
2Viral Immunology and Respiratory Disease Group, University of Newcastle, Newcastle, Australia
3Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia
4Department of Microbiology and Immunology, University of Melbourne, Melbourne, Australia
5Ena Therapeutics Pty Ltd, Ena Therapeutics Pty Ltd, Melbourne, Australia
Find articles by
Scott, N.
in:
JCI
|
PubMed
|
Google Scholar
|
1Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia
2Viral Immunology and Respiratory Disease Group, University of Newcastle, Newcastle, Australia
3Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia
4Department of Microbiology and Immunology, University of Melbourne, Melbourne, Australia
5Ena Therapeutics Pty Ltd, Ena Therapeutics Pty Ltd, Melbourne, Australia
Find articles by Londrigan, S. in: JCI | PubMed | Google Scholar
1Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia
2Viral Immunology and Respiratory Disease Group, University of Newcastle, Newcastle, Australia
3Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia
4Department of Microbiology and Immunology, University of Melbourne, Melbourne, Australia
5Ena Therapeutics Pty Ltd, Ena Therapeutics Pty Ltd, Melbourne, Australia
Find articles by
Reading, P.
in:
JCI
|
PubMed
|
Google Scholar
|
1Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia
2Viral Immunology and Respiratory Disease Group, University of Newcastle, Newcastle, Australia
3Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia
4Department of Microbiology and Immunology, University of Melbourne, Melbourne, Australia
5Ena Therapeutics Pty Ltd, Ena Therapeutics Pty Ltd, Melbourne, Australia
Find articles by
Bartlett, N.
in:
JCI
|
PubMed
|
Google Scholar
|
1Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia
2Viral Immunology and Respiratory Disease Group, University of Newcastle, Newcastle, Australia
3Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia
4Department of Microbiology and Immunology, University of Melbourne, Melbourne, Australia
5Ena Therapeutics Pty Ltd, Ena Therapeutics Pty Ltd, Melbourne, Australia
Find articles by
Kedzierska, K.
in:
JCI
|
PubMed
|
Google Scholar
|
1Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia
2Viral Immunology and Respiratory Disease Group, University of Newcastle, Newcastle, Australia
3Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia
4Department of Microbiology and Immunology, University of Melbourne, Melbourne, Australia
5Ena Therapeutics Pty Ltd, Ena Therapeutics Pty Ltd, Melbourne, Australia
Find articles by Brown, L. in: JCI | PubMed | Google Scholar
1Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia
2Viral Immunology and Respiratory Disease Group, University of Newcastle, Newcastle, Australia
3Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia
4Department of Microbiology and Immunology, University of Melbourne, Melbourne, Australia
5Ena Therapeutics Pty Ltd, Ena Therapeutics Pty Ltd, Melbourne, Australia
Find articles by Mercuri, F. in: JCI | PubMed | Google Scholar
1Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia
2Viral Immunology and Respiratory Disease Group, University of Newcastle, Newcastle, Australia
3Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia
4Department of Microbiology and Immunology, University of Melbourne, Melbourne, Australia
5Ena Therapeutics Pty Ltd, Ena Therapeutics Pty Ltd, Melbourne, Australia
Find articles by Demaison, C. in: JCI | PubMed | Google Scholar
1Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia
2Viral Immunology and Respiratory Disease Group, University of Newcastle, Newcastle, Australia
3Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia
4Department of Microbiology and Immunology, University of Melbourne, Melbourne, Australia
5Ena Therapeutics Pty Ltd, Ena Therapeutics Pty Ltd, Melbourne, Australia
Find articles by
Jackson, D.
in:
JCI
|
PubMed
|
Google Scholar
|
1Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia
2Viral Immunology and Respiratory Disease Group, University of Newcastle, Newcastle, Australia
3Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia
4Department of Microbiology and Immunology, University of Melbourne, Melbourne, Australia
5Ena Therapeutics Pty Ltd, Ena Therapeutics Pty Ltd, Melbourne, Australia
Find articles by
Chua, B.
in:
JCI
|
PubMed
|
Google Scholar
|
Published February 9, 2021 - More info
The impact of respiratory virus infections on global health is felt not just during a pandemic but for many, endemic seasonal infections pose an equal and ongoing risk of severe disease. Moreover, vaccines and antiviral drugs are not always effective or available for many respiratory viruses. We investigated how induction of effective and appropriate antigen independent innate immunity in the upper airways can prevent spread of respiratory virus infection to the vulnerable lower airways. Activation of Toll-like receptor-2 (TLR2), when restricted to the nasal turbinates results in prompt induction of innate immune-driven anti-viral responses through action of cytokines, chemokines and cellular activity in the upper but not the lower airways. We define how nasal epithelial cells and recruitment of macrophages work in concert and play pivotal roles to limit progression of influenza virus to the lungs and sustain protection for up to seven days. These results reveal underlying mechanisms of how control of viral infection in the upper airways can occur and also support the implementation of strategies that can activate TLR2 in nasal passages to provide rapid protection, especially for at-risk populations, against severe respiratory infection when vaccines and antiviral drugs are not always effective or available.